UniProt Q04771
Activin receptor type-1 (Q04771)
Activin receptor type-1 (UniProt Q04771), EC 2.7.11.30: 127 experimental structures and 1 predicted model on GenesisL1, 73 ligands bound, 245 pockets. Binding sites, druggability and experiment against prediction (TM-score) in…
- UniProt
- Q04771
- Protein
- Activin receptor type-1
- EC
- 2.7.11.30
- Experimental structures
- 127
- Predicted models
- 1
- Ligands
- 73
- Pockets
- 245 · 38 records with a druggable one
Structures
128 records of Q04771 in the MolNFT archive: 127 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 3H9R | Crystal structure of the kinase domain of type I activin receptor (ACVR1) in complex with FKBP12… | x-ray diffraction | A | — | — |
| 3H9R | Crystal structure of the kinase domain of type I activin receptor (ACVR1) in complex with FKBP12… | x-ray diffraction | A | — | — |
| 3MTF | Crystal structure of the ACVR1 kinase in complex with a 2-aminopyridine inhibitor | x-ray diffraction | A, B | — | — |
| 3MTF | Crystal structure of the ACVR1 kinase in complex with a 2- aminopyridine inhibitor | x-ray diffraction | A, B | — | — |
| 3OOM | Crystal structure of the ACVR1 kinase domain in complex with the imidazo[1,2-b]pyridazine inhibitor… | x-ray diffraction | A | — | — |
| 3OOM | Crystal structure of the ACVR1 kinase domain in complex with the IMIDAZO[1,2-B]PYRIDAZINE inhibitor… | x-ray diffraction | A | — | — |
| 3Q4U | Crystal structure of the ACVR1 kinase domain in complex with LDN-193189 | x-ray diffraction | A, B, C, D | — | — |
| 3Q4U | Crystal structure of the ACVR1 kinase domain in complex with ldn- 193189 | x-ray diffraction | A, B, C, D | — | — |
| 4BGG | Crystal structure of the ACVR1 kinase in complex with LDN-213844 | x-ray diffraction | A, B, C, D | — | — |
| 4BGG | Crystal structure of the ACVR1 kinase in complex with ldn-213844 | x-ray diffraction | A, B, C, D | — | — |
| 4C02 | Crystal structure of human ACVR1 (ALK2) in complex with FKBP12.6 and dorsomorphin | x-ray diffraction | A | — | — |
| 4C02 | Crystal structure of human ACVR1 (ALK2) in complex with FKBP12.6 and dorsomorphin | x-ray diffraction | A | — | — |
| 4DYM | Crystal structure of the ACVR1 kinase domain in complex with the imidazo[1,2-b]pyridazine inhibitor… | x-ray diffraction | A | — | — |
| 4DYM | Crystal structure of the ACVR1 kinase domain in complex with the IMIDAZO[1,2-B]PYRIDAZINE inhibitor… | x-ray diffraction | A | — | — |
| 5OXG | Crystal structure of the ACVR1 (ALK2) kinase in complex with ldn- 212854 | x-ray diffraction | A, B, C, D | B4B, CA | — |
| 5OY6 | Crystal structure of the ACVR1 (ALK2) kinase in complex with cyclical inhibitor OD36. | x-ray diffraction | A, B, C, D | B4E | — |
| 5S75 | XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010913a | x-ray diffraction | A, B | LU8, SRT, HUH, SO4 | 7 (best 0.69) |
| 5S75 | Xchem group deposition -- crystal structure of human ACVR1 in complex with FM010913A | x-ray diffraction | A, B | LU8, SRT, HUH, SO4 | — |
| 5S76 | XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010916a | x-ray diffraction | A, B | LU8, 02A, SO4 | 4 (best 0.70) |
| 5S76 | Xchem group deposition -- crystal structure of human ACVR1 in complex with FM010916A | x-ray diffraction | A, B | LU8, 02A, SO4 | — |
| 5S77 | XChem group deposition -- Crystal Structure of human ACVR1 in complex with XS035133b | x-ray diffraction | A, B | LU8, BAQ, SO4 | 7 (best 0.69) |
| 5S77 | Xchem group deposition -- crystal structure of human ACVR1 in complex with XS035133B | x-ray diffraction | A, B | LU8, BAQ, SO4 | — |
| 5S78 | XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010934a | x-ray diffraction | A, B | LU8, XGV, SO4 | — |
| 5S78 | Xchem group deposition -- crystal structure of human ACVR1 in complex with FM010934A | x-ray diffraction | A, B | LU8, XGV, SO4 | — |
| 5S79 | Xchem group deposition -- crystal structure of human ACVR1 in complex with FM010910A | x-ray diffraction | A, B | LU8, SO4, PZO | — |
| 5S7A | XChem group deposition -- Crystal Structure of human ACVR1 in complex with PK012456b | x-ray diffraction | A, B | LU8, T5V, SO4 | 7 (best 0.70) |
| 5S7A | Xchem group deposition -- crystal structure of human ACVR1 in complex with PK012456B | x-ray diffraction | A, B | LU8, T5V, SO4 | — |
| 5S7B | XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM000329d | x-ray diffraction | A, B | LU8, XH7, SO4 | 6 (best 0.71) |
| 5S7B | Xchem group deposition -- crystal structure of human ACVR1 in complex with FM000329D | x-ray diffraction | A, B | LU8, XH7, SO4 | — |
| 5S7C | XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM000274c | x-ray diffraction | A, B | LU8, T5Y, SO4 | 8 (best 0.68) |
| 5S7C | Xchem group deposition -- crystal structure of human ACVR1 in complex with FM000274C | x-ray diffraction | A, B | LU8, T5Y, SO4 | — |
| 5S7D | Xchem group deposition -- crystal structure of human ACVR1 in complex with FM010923A | x-ray diffraction | A, B | LU8, XHD, SO4 | — |
| 5S7E | Xchem group deposition -- crystal structure of human ACVR1 in complex with FM010930A | x-ray diffraction | A, B | LU8, SO4, XEA | — |
| 5S7F | XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010935a | x-ray diffraction | A, B | LU8, SO4, XH4 | 8 (best 0.68) |
| 5S7F | Xchem group deposition -- crystal structure of human ACVR1 in complex with FM010935A | x-ray diffraction | A, B | LU8, SO4, XH4 | — |
| 5S7G | Xchem group deposition -- crystal structure of human ACVR1 in complex with XS035844B | x-ray diffraction | A, B | LU8, SO4 | — |
| 5S7H | XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010914a | x-ray diffraction | A, B | LU8, HVB, SO4 | 7 (best 0.69) |
| 5S7H | Xchem group deposition -- crystal structure of human ACVR1 in complex with FM010914A | x-ray diffraction | A, B | LU8, HVB, SO4 | — |
| 5S7I | XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010928a | x-ray diffraction | A, B | LU8, HV2, SO4 | 7 (best 0.71) |
| 5S7I | Xchem group deposition -- crystal structure of human ACVR1 in complex with FM010928A | x-ray diffraction | A, B | LU8, HV2, SO4 | — |
| 5S7J | XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM000893d | x-ray diffraction | A, B | LU8, XHG, SO4 | — |
| 5S7J | Xchem group deposition -- crystal structure of human ACVR1 in complex with FM000893D | x-ray diffraction | A, B | LU8, XHG, SO4 | — |
| 5S7K | XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010936a | x-ray diffraction | A, B | LU8, XEJ, SO4 | 7 (best 0.70) |
| 5S7K | Xchem group deposition -- crystal structure of human ACVR1 in complex with FM010936A | x-ray diffraction | A, B | LU8, XEJ, SO4 | — |
| 5S7L | XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010943a | x-ray diffraction | A, B | LU8, XHJ, SO4 | 7 (best 0.69) |
| 5S7L | Xchem group deposition -- crystal structure of human ACVR1 in complex with FM010943A | x-ray diffraction | A, B | LU8, XHJ, SO4 | — |
| 5S7M | XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM000275d | x-ray diffraction | A, B | LU8, HVK, SO4 | 7 (best 0.74) |
| 5S7M | Xchem group deposition -- crystal structure of human ACVR1 in complex with FM000275D | x-ray diffraction | A, B | LU8, HVK, SO4 | — |
| 5S7N | Xchem group deposition -- crystal structure of human ACVR1 in complex with FM010920A | x-ray diffraction | A, B | LU8, 2AI, SO4 | — |
| 5S7O | XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM007391c | x-ray diffraction | A, B | LU8, SO4, XJJ | 6 (best 0.69) |
| 5S7O | Xchem group deposition -- crystal structure of human ACVR1 in complex with FM007391C | x-ray diffraction | A, B | LU8, SO4, XJJ | — |
| 5S7P | Xchem group deposition -- crystal structure of human ACVR1 in complex with FM010937A | x-ray diffraction | A, B | LU8, V1L, SO4 | — |
| 5S7Q | XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010944a | x-ray diffraction | A, B | LU8, SO4, XJM | 7 (best 0.70) |
| 5S7Q | Xchem group deposition -- crystal structure of human ACVR1 in complex with FM010944A | x-ray diffraction | A, B | LU8, SO4, XJM | — |
| 5S7R | XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010918a | x-ray diffraction | A, B | LU8, XGS, SO4 | 5 (best 0.70) |
| 5S7R | Xchem group deposition -- crystal structure of human ACVR1 in complex with FM010918A | x-ray diffraction | A, B | LU8, XGS, SO4 | — |
| 5S7S | XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010921a | x-ray diffraction | A, B | LU8, 09V, SO4 | 6 (best 0.70) |
| 5S7S | Xchem group deposition -- crystal structure of human ACVR1 in complex with FM010921A | x-ray diffraction | A, B | LU8, 09V, SO4 | — |
| 5S7T | XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010926a | x-ray diffraction | A, B | LU8, XGJ, SO4 | 7 (best 0.71) |
| 5S7T | Xchem group deposition -- crystal structure of human ACVR1 in complex with FM010926A | x-ray diffraction | A, B | LU8, XGJ, SO4 | — |
68 records more on the page itself.
Ligands
- SO4 · Sulfate ion · in 99 records
- LU8 · 4-methyl-3-[4-(1-methylpiperidin-4-yl)phenyl]-5-(3,4,5-trimethoxyphenyl)pyridine · in 78 records
- NH4 · Ammonium ion · in 4 records
- PO4 · Phosphate ion · in 3 records
- 02A · (2S)-azetidine-2-carboxylic acid · in 2 records
- 09V · cyclopropylmethanol · in 2 records
- 5U6 · 4-[4-[(dimethylamino)methyl]-2,5-dimethoxy-phenyl]-2-methyl-2,7-naphthyridin-1-one · in 2 records
- 9TO · N-(4-methoxyphenyl)-4-[3-(pyridin-3-yl)-1H-pyrazol-4-yl]pyrimidin-2-amine · in 2 records
- A3F · 3-[6-amino-5-(3,4,5-trimethoxyphenyl)pyridin-3-yl]phenol · in 2 records
- ANP · Phosphoaminophosphonic acid-adenylate ester · in 2 records
- BAQ · pyrrolidin-2-one · in 2 records
- BYZ · 4-bromo-1H-pyrazole · in 2 records
- C9U · 4-(1-ethyl-3-pyridin-3-yl-pyrazol-4-yl)-~{N}-(4-piperazin-1-ylphenyl)pyrimidin-2-amine · in 2 records
- EUN · 2,5-dimethyl-6-quinolin-4-yl-3~{H}-quinazolin-4-one · in 2 records
- FH0 · ~{N}-[4-(4-methylpiperazin-1-yl)phenyl]-4-(2-pyridin-3-yl-6,7-dihydro-4~{H}-pyrazolo[5,1-c][1,4]oxazin-3-yl) pyrimidin-2-amine · in 2 records
- HUH · 1~{H}-1,2,3-triazole · in 2 records
- HV2 · 1,1-bis(oxidanylidene)thietan-3-ol · in 2 records
- HVB · 1-azanylpropylideneazanium · in 2 records
- HVK · pyridin-2-amine · in 2 records
- LAC · Lactic acid · in 2 records
- LGA · Pyrimidin-2-amine · in 2 records
- MG · Magnesium ion · in 2 records
- MVE · cyclopropyl-[4-[6-[5-(4-ethoxy-1-propan-2-yl-piperidin-4-yl)pyridin-2-yl]pyrrolo[1,2-b]pyridazin-4-yl]piperazin-1-yl]methanone · in 2 records
- Q5Z · 4-methyl-3-(4-piperidin-4-ylphenyl)-5-(3,4,5-trimethoxyphenyl)pyridine · in 2 records
- QWQ · 4-methyl-3-[4-(pyrrolidin-1-ylmethyl)phenyl]-5-(3,4,5-trimethoxyphenyl)pyridine · in 2 records
- SRT · S,R meso-tartaric acid · in 2 records
- T5V · pyrimidin-5-amine · in 2 records
- T5Y · pyridin-2-ol · in 2 records
- XEJ · (3R)-3-aminobutanamide · in 2 records
- XGJ · (3S)-1,2,4-triazolidin-3-amine · in 2 records
Experiment against prediction
- 9D8Z chain A against the predicted model Q04771: TM-score 0.97, RMSD 1.16 Å
- 6UNQ chain A against the predicted model Q04771: TM-score 0.97, RMSD 1.26 Å
- 4BGG chain D against the predicted model Q04771: TM-score 0.97, RMSD 1.31 Å
- 4BGG chain D against the predicted model Q04771: TM-score 0.97, RMSD 1.31 Å
- 9D8F chain B against the predicted model Q04771: TM-score 0.97, RMSD 1.20 Å
- 6T6D chain A against the predicted model Q04771: TM-score 0.97, RMSD 1.28 Å
- 6T6D chain C against the predicted model Q04771: TM-score 0.97, RMSD 1.30 Å
- 6ACR chain A against the predicted model Q04771: TM-score 0.97, RMSD 1.34 Å
- 6ACR chain A against the predicted model Q04771: TM-score 0.97, RMSD 1.34 Å
- 6UNS chain A against the predicted model Q04771: TM-score 0.97, RMSD 1.35 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.